Literature DB >> 8650244

Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers.

T Nobori1, K Takabayashi, P Tran, L Orvis, A Batova, A L Yu, D A Carson.   

Abstract

5'-Deoxy-5'-methylthioadenosine phosphorylase (methylthioadeno-sine: ortho-phosphate methylthioribosyltransferase, EC 24.2.28; MTAP) plays a role in purine and polyamine metabolism and in the regulation of transmethylation reactions. MTAP is abundant in normal cells but is deficient in many cancers. Recently, the genes for the cyclin-dependent kinase inhibitors p16 and p15 have been localized to the short arm of human chromosome 9 at band p21, where MTAP and interferon alpha genes (IFNA) also map. Homozygous deletions of p16 and p15 are frequent malignant cell lines. However, the order of the MTAP, p16, p15, and IFNA genes on chromosome 9p is uncertain, and the molecular basis for MTAP deficiency in cancer is unknown. We have cloned the MTAP gene, and have constructed a topologic map of the 9p21 region using yeast artificial chromosome clones, pulse-field gel electrophoresis, and sequence-tagged-site PCR. The MTAP gene consists of eight exons and seven introns. Of 23 malignant cell lines deficient in MTAP protein, all but one had complete or partial deletions. Partial or total deletions of the MTAP gene were found in primary T-cell acute lymphoblastic leukemias (T-ALL). A deletion breakpoint of partial deletions found in cell lines and primary T-ALL was in intron 4. Starting from the centromeric end, the gene order on chromosome 9p2l is p15, p16, MTAP, IFNA, and interferon beta gene (IFNB). These results indicate that MTAP deficiency in cancer is primarily due to codeletion of the MTAP and p16 genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8650244      PMCID: PMC39214          DOI: 10.1073/pnas.93.12.6203

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer.

Authors:  J Whang-Peng; T Knutsen; A Gazdar; S M Steinberg; H Oie; I Linnoila; J Mulshine; M Nau; J D Minna
Journal:  Genes Chromosomes Cancer       Date:  1991-05       Impact factor: 5.006

2.  Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines.

Authors:  H M Pomykala; S K Bohlander; P L Broeker; O I Olopade; M O Díaz
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

3.  Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.

Authors:  O I Olopade; R B Jenkins; D T Ransom; K Malik; H Pomykala; T Nobori; J M Cowan; J D Rowley; M O Diaz
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

4.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers.

Authors:  T Nobori; K Miura; D J Wu; A Lois; K Takabayashi; D A Carson
Journal:  Nature       Date:  1994-04-21       Impact factor: 49.962

5.  A cell cycle regulator potentially involved in genesis of many tumor types.

Authors:  A Kamb; N A Gruis; J Weaver-Feldhaus; Q Liu; K Harshman; S V Tavtigian; E Stockert; R S Day; B E Johnson; M H Skolnick
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

6.  Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers.

Authors:  T Nobori; I Szinai; D Amox; B Parker; O I Olopade; D L Buchhagen; D A Carson
Journal:  Cancer Res       Date:  1993-03-01       Impact factor: 12.701

7.  Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma.

Authors:  C Caldas; S A Hahn; L T da Costa; M S Redston; M Schutte; A B Seymour; C L Weinstein; R H Hruban; C J Yeo; S E Kern
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

8.  p16 gene homozygous deletions in acute lymphoblastic leukemia.

Authors:  B Quesnel; C Preudhomme; N Philippe; M Vanrumbeke; I Dervite; J L Lai; F Bauters; E Wattel; P Fenaux
Journal:  Blood       Date:  1995-02-01       Impact factor: 22.113

9.  Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias.

Authors:  S Ogawa; N Hirano; N Sato; T Takahashi; A Hangaishi; K Tanaka; M Kurokawa; T Tanaka; K Mitani; Y Yazaki
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

10.  Deletion of p16 and p15 genes in brain tumors.

Authors:  J Jen; J W Harper; S H Bigner; D D Bigner; N Papadopoulos; S Markowitz; J K Willson; K W Kinzler; B Vogelstein
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

View more
  33 in total

1.  Nucleolar targeting of coilin is regulated by its hypomethylation state.

Authors:  Olga Tapia; Rocio Bengoechea; Maria T Berciano; Miguel Lafarga
Journal:  Chromosoma       Date:  2010-05-07       Impact factor: 4.316

2.  MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.

Authors:  Gregory V Kryukov; Frederick H Wilson; Jason R Ruth; Joshiawa Paulk; Aviad Tsherniak; Sara E Marlow; Francisca Vazquez; Barbara A Weir; Mark E Fitzgerald; Minoru Tanaka; Craig M Bielski; Justin M Scott; Courtney Dennis; Glenn S Cowley; Jesse S Boehm; David E Root; Todd R Golub; Clary B Clish; James E Bradner; William C Hahn; Levi A Garraway
Journal:  Science       Date:  2016-02-11       Impact factor: 47.728

3.  Mice heterozygous for germ-line mutations in methylthioadenosine phosphorylase (MTAP) die prematurely of T-cell lymphoma.

Authors:  Yuwaraj Kadariya; Bu Yin; Baiqing Tang; Susan A Shinton; Eoin P Quinlivan; Xiang Hua; Andres Klein-Szanto; Tahseen I Al-Saleem; Craig H Bassing; Richard R Hardy; Warren D Kruger
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

4.  Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays.

Authors:  Inês Crespo; Ana Luísa Vital; Ana Belen Nieto; Olinda Rebelo; Hermínio Tão; Maria Celeste Lopes; Catarina Resende Oliveira; Pim J French; Alberto Orfao; María Dolores Tabernero
Journal:  J Mol Diagn       Date:  2011-08-30       Impact factor: 5.568

5.  Loss of p16INK4A expression is associated with allelic imbalance/loss of heterozygosity of chromosome 9p21 in microdissected synovial sarcomas.

Authors:  Muna Sabah; Robert Cummins; Mary Leader; Elaine Kay
Journal:  Virchows Arch       Date:  2005-08-05       Impact factor: 4.064

6.  Increasing the therapeutic index of 5-fluorouracil and 6-thioguanine by targeting loss of MTAP in tumor cells.

Authors:  Baiqing Tang; Joseph R Testa; Warren D Kruger
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

7.  Mapping autosomal dominant progressive limb-girdle myopathy with bone fragility to chromosome 9p21-p22: a novel locus for a musculoskeletal syndrome.

Authors:  Giles D J Watts; Sarju G Mehta; Chengfeng Zhao; Sheena Ramdeen; Sara Jane Hamilton; Deborah V Novack; Steven Mumm; Michael P Whyte; Barbara Mc Gillivray; Virginia E Kimonis
Journal:  Hum Genet       Date:  2005-10-22       Impact factor: 4.132

Review 8.  The emerging genetic architecture of type 2 diabetes.

Authors:  Alessandro Doria; Mary-Elizabeth Patti; C Ronald Kahn
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

Review 9.  Long Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular Disease.

Authors:  Francesca Aguilo; Serena Di Cecilia; Martin J Walsh
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

10.  Different molecular mechanisms causing 9p21 deletions in acute lymphoblastic leukemia of childhood.

Authors:  Francesca Novara; Silvana Beri; Maria Ester Bernardo; Riccardo Bellazzi; Alberto Malovini; Roberto Ciccone; Angela Maria Cometa; Franco Locatelli; Roberto Giorda; Orsetta Zuffardi
Journal:  Hum Genet       Date:  2009-05-30       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.